The Medtronic RESOLUTE US Clinical Trial (R-US)
Trial ID or NCT#
NCT00726453
Status
NOT RECRUITING
Purpose
The objective of the study is to assess the safety and effectiveness of the Resolute Zotarolimus-Eluting Coronary Stent System for the treatment of de novo lesions in native coronary arteries with a reference vessel diameter (RVD) of 2.25 mm to 4.2 mm.
Investigator(s)
Alan Yeung, MD
View on